Session

Liver & biliary (Posters)

RISK OF DEVELOPING PRIMARY BILIARY CHOLANGITIS IN PATIENTS WITH ISOLATED POSITIVE ANTI-MITOCHONDRIAL (AMA) ANTIBODIES
RISK OF DEVELOPING PRIMARY BILIARY CHOLANGITIS IN PATIENTS WITH ISOLATED POSITIVE ANTI-MITOCHONDRIAL (AMA) ANTIBODIES

Liver & biliary (Posters)  et al.

THE CHALLENGE OF OUTRULING CONCOMINANT CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS WAIT-LISTED FOR LIVER TRANSPLANTATION: THE IRISH NATIONAL EXPERIENCE
THE CHALLENGE OF OUTRULING CONCOMINANT CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS WAIT-LISTED FOR LIVER TRANSPLANTATION: THE IRISH NATIONAL EXPERIENCE

Liver & biliary (Posters)  et al.

FUNCTIONAL DYSPEPSIA AND IRRITABLE BOWEL SYNDROME NEGATIVELY AFFECT PATIENT REPORTED OUTCOMES AFTER CHOLECYSTECTOMY: A PROSPECTIVE, MULTICENTRE, OBSERVATIONAL STUDY (PERFECT - TRIAL)
FUNCTIONAL DYSPEPSIA AND IRRITABLE BOWEL SYNDROME NEGATIVELY AFFECT PATIENT REPORTED OUTCOMES AFTER CHOLECYSTECTOMY: A PROSPECTIVE, MULTICENTRE, OBSERVATIONAL STUDY (PERFECT - TRIAL)

Liver & biliary (Posters)  et al.

THE ROLE OF DIABETES MELLITUS IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS-INFECTED PATIENTS TREATED WITH DIRECT-ACTING ANTIVIRALS: A META-ANALYSIS
THE ROLE OF DIABETES MELLITUS IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS-INFECTED PATIENTS TREATED WITH DIRECT-ACTING ANTIVIRALS: A META-ANALYSIS

Liver & biliary (Posters)  et al.

TELEMEDICINE IN HEPATOLOGY AND PATIENT SATISFACTION: LESSONS FROM THE COVID-19 PANDEMIC
TELEMEDICINE IN HEPATOLOGY AND PATIENT SATISFACTION: LESSONS FROM THE COVID-19 PANDEMIC

Liver & biliary (Posters)  et al.

ULTRA-PROCESSED FOOD INTAKE IS ASSOCIATED WITH FEATURES OF METABOLIC SYNDROME AND LIVER DAMAGE
ULTRA-PROCESSED FOOD INTAKE IS ASSOCIATED WITH FEATURES OF METABOLIC SYNDROME AND LIVER DAMAGE

Liver & biliary (Posters)  et al.

LYMPHOCYTE TO MONOCYTE RATIO CAN BE A SIMPLE AND NOVEL PREDICTOR IN CIRRHOTIC PATIENTS WITH CULTURE NEGATIVE NEUTROCYTIC ASCITES
LYMPHOCYTE TO MONOCYTE RATIO CAN BE A SIMPLE AND NOVEL PREDICTOR IN CIRRHOTIC PATIENTS WITH CULTURE NEGATIVE NEUTROCYTIC ASCITES

Liver & biliary (Posters)  et al.

MALNUTRITION AND MORTALITY RISK IN LIVER CIRRHOSIS PATIENTS
MALNUTRITION AND MORTALITY RISK IN LIVER CIRRHOSIS PATIENTS

Liver & biliary (Posters)  et al.

NUTRITIONAL PATTERNS OF PATIENTS WITH NAFLD SIGNIFICANTLY DIFFER TO THOSE IN A CONTROL GROUP
NUTRITIONAL PATTERNS OF PATIENTS WITH NAFLD SIGNIFICANTLY DIFFER TO THOSE IN A CONTROL GROUP

Liver & biliary (Posters)  et al.

SAFETY, EFFICACY AND COST-EFFECTIVENESS OF GLASGOW MODIFIED ALCOHOL WITHDRAWAL SCALE AND SYMPTOM-TRIGGERED DOSING REGIMEN FOR THE MANAGEMENT OF ACUTE ALCOHOL WITHDRAWAL SYNDROME IN AINTREE UNIVERSITY TEACHING HOSPITAL
SAFETY, EFFICACY AND COST-EFFECTIVENESS OF GLASGOW MODIFIED ALCOHOL WITHDRAWAL SCALE AND SYMPTOM-TRIGGERED DOSING REGIMEN FOR THE MANAGEMENT OF ACUTE ALCOHOL WITHDRAWAL SYNDROME IN AINTREE UNIVERSITY TEACHING HOSPITAL

Liver & biliary (Posters)  et al.

DAY-4 LILLE SCORE IN EARLY PREDICTION OF CORTICOSTEROID RESPONSE FOR PATIENTS WITH SEVERE ACUTE ALCOHOLIC HEPATITIS
DAY-4 LILLE SCORE IN EARLY PREDICTION OF CORTICOSTEROID RESPONSE FOR PATIENTS WITH SEVERE ACUTE ALCOHOLIC HEPATITIS

Liver & biliary (Posters)  et al.

PROGRESSION-FREE SURVIVAL IS A CONSISTENT SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
PROGRESSION-FREE SURVIVAL IS A CONSISTENT SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS

Liver & biliary (Posters)  et al.

A TREATMENT TO CONSIDER: MULTIVISCERAL TRANSPLANTATION FOR PORTO-MESENTERIC VENOUS THROMBOSIS
A TREATMENT TO CONSIDER: MULTIVISCERAL TRANSPLANTATION FOR PORTO-MESENTERIC VENOUS THROMBOSIS

Liver & biliary (Posters)  et al.

NON-ALCOHOLIC FATTY LIVER DISEASE INVOLVES DEVIATIONS IN MICRORNAS AND HEMATOLOGICAL INDICES - A SINGLE CENTRE OBSERVATION
NON-ALCOHOLIC FATTY LIVER DISEASE INVOLVES DEVIATIONS IN MICRORNAS AND HEMATOLOGICAL INDICES - A SINGLE CENTRE OBSERVATION

Liver & biliary (Posters)  et al.

REAL WORLD EFFICACY AND SAFETY OF SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION: A COHORT STUDY
REAL WORLD EFFICACY AND SAFETY OF SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION: A COHORT STUDY

Liver & biliary (Posters)  et al.

ESTIMATED ANNUAL LIVER GROWTH PREDICTS NEED FOR TREATMENT IN POLYCYSTIC LIVER DISEASE
ESTIMATED ANNUAL LIVER GROWTH PREDICTS NEED FOR TREATMENT IN POLYCYSTIC LIVER DISEASE

Liver & biliary (Posters)  et al.

A MURINE MODEL OF HEPATIC ENCEPHALOPATHY: VALIDATION AND NEUROBEHAVIORAL TESTING
A MURINE MODEL OF HEPATIC ENCEPHALOPATHY: VALIDATION AND NEUROBEHAVIORAL TESTING

Liver & biliary (Posters)  et al.

OPTIMIZING SEQUENTIAL SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELULLAR CARCINOMA: A DECISION ANALYSIS
OPTIMIZING SEQUENTIAL SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELULLAR CARCINOMA: A DECISION ANALYSIS

Liver & biliary (Posters)  et al.

SERUM MIR-421 AND LNCRNA MEG3 AS BIOMARKERS FOR THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
SERUM MIR-421 AND LNCRNA MEG3 AS BIOMARKERS FOR THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN

Liver & biliary (Posters)  et al.

RISK OF OCCURRENCE AND RECURRENCE OF HEPATOCELLULAR CARCINOMA IN 349 PATIENTS WITH LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION GENOTYPE 1 B TREATED WITH SOFOSBUVIR+LEDIPASVIR± RIBAVIRIN
RISK OF OCCURRENCE AND RECURRENCE OF HEPATOCELLULAR CARCINOMA IN 349 PATIENTS WITH LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION GENOTYPE 1 B TREATED WITH SOFOSBUVIR+LEDIPASVIR± RIBAVIRIN

Liver & biliary (Posters)  et al.

Item 81 - 100 / 167
1 2 3 4
5
6 7 8 9